C Allred

945 total citations
19 papers, 784 citations indexed

About

C Allred is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, C Allred has authored 19 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in C Allred's work include Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). C Allred is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). C Allred collaborates with scholars based in United States, United Kingdom and Switzerland. C Allred's co-authors include Wen‐Hwa Lee, Frank Hong, Pascale Rio, Steven A. Madreperla, William E. Grizzle, Robert Bookstein, Alan G. Barbour, C. O. Solberg, H. R. Hill and Takeshi Yoshida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

C Allred

17 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Allred United States 10 256 202 194 161 145 19 784
J. Bradford Kline United States 17 354 1.4× 379 1.9× 153 0.8× 73 0.5× 230 1.6× 29 1.1k
Matthew L. Hedberg United States 11 202 0.8× 219 1.1× 117 0.6× 104 0.6× 75 0.5× 20 601
Howard B. Urnovitz United States 17 323 1.3× 328 1.6× 150 0.8× 290 1.8× 185 1.3× 41 973
Jürgen Siebler Germany 16 380 1.5× 304 1.5× 141 0.7× 84 0.5× 250 1.7× 60 1.1k
Bert Top Netherlands 17 375 1.5× 419 2.1× 239 1.2× 164 1.0× 42 0.3× 31 990
Sâmia Demachki Brazil 21 204 0.8× 558 2.8× 160 0.8× 357 2.2× 148 1.0× 73 1.1k
Paul I. Nadler United States 20 243 0.9× 222 1.1× 105 0.5× 65 0.4× 326 2.2× 49 1.0k
J Zeromski Poland 19 255 1.0× 265 1.3× 105 0.5× 128 0.8× 537 3.7× 98 1.2k
Hsin‐Pai Li Taiwan 15 295 1.2× 409 2.0× 77 0.4× 177 1.1× 156 1.1× 29 943
L. Athlin Sweden 12 324 1.3× 223 1.1× 165 0.9× 102 0.6× 264 1.8× 34 911

Countries citing papers authored by C Allred

Since Specialization
Citations

This map shows the geographic impact of C Allred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Allred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Allred more than expected).

Fields of papers citing papers by C Allred

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Allred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Allred. The network helps show where C Allred may publish in the future.

Co-authorship network of co-authors of C Allred

This figure shows the co-authorship network connecting the top 25 collaborators of C Allred. A scholar is included among the top collaborators of C Allred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Allred. C Allred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lowry, K. G., et al.. (2025). The Impact of Peripheral Vascular Motion on Acute Drug Retention of Intravascular Devices. Cardiovascular Engineering and Technology. 16(3). 322–332.
2.
Allred, C, et al.. (2023). Design and use of an ex vivo peripheral simulating bioreactor system for pharmacokinetic analysis of a drug coated stent. Bioengineering & Translational Medicine. 9(2). e10618–e10618. 5 indexed citations
3.
Hill, H. R., Ann O. Shigeoka, Neal S. Rote, C Allred, & V G Hemming. (2015). Methods of Assessment and Importance of Opsonic Activity for GBS. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 35. 157–169.
4.
Muthigi, Akhil, C Allred, Yang Jia, et al.. (2013). ANCA disease patients with increased expression of autoantigen genes produce an alternative PR3 transcript and synthesize autoantigen proteins. La Presse Médicale. 42(4). 669–669. 1 indexed citations
5.
Suman, Vera J., Lisa McCall, Rui Luo, et al.. (2012). Abstract PD07-01: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy Based on 2 to 4 week Ki67 level > 10%.. Cancer Research. 72(24_Supplement). PD07–1. 12 indexed citations
6.
7.
Ellis, Matthew J., Jingqin Luo, Yu Tao, et al.. (2009). Tumor Ki67 Proliferation Index within 4 Weeks of Initiating Neoadjuvant Endocrine Therapy for Early Identification of Non-Responders.. Cancer Research. 69(24_Supplement). 78–78. 6 indexed citations
8.
Delmas, P. D., Richard Eastell, Kristine E. Ensrud, et al.. (2009). Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women.. Cancer Research. 69(2_Supplement). 11–11. 4 indexed citations
9.
Bryant, Jennifer, C Allred, James J. Dignam, et al.. (2003). DCIS: evidence from radomized trials. The Breast. 12. S9–S9. 2 indexed citations
10.
Pennington, Pamela M., et al.. (1997). Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infection and Immunity. 65(1). 285–292. 61 indexed citations
11.
Brown, Richard W., C Allred, Gary M. Clark, C. Kent Osborne, & Susan G. Hilsenbeck. (1996). Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.. PubMed. 2(3). 585–92. 90 indexed citations
12.
Makris, Andreas, T.J. Powles, C Allred, & Mitch Dowsett. (1995). 668 P53 Mutation and chemosensitivity in breast cancer patients. European Journal of Cancer. 31. S140–S140. 1 indexed citations
13.
Bookstein, Robert, Pascale Rio, Steven A. Madreperla, et al.. (1990). Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.. Proceedings of the National Academy of Sciences. 87(19). 7762–7766. 278 indexed citations
14.
Kobayashi, Katsuya, C Allred, Richard J. Castriotta, & Takeshi Yoshida. (1985). Strain variation of bacillus Calmette-Guerin-induced pulmonary granuloma formation is correlated with anergy and the local production of migration inhibition factor and interleukin 1.. PubMed. 119(2). 223–35. 33 indexed citations
15.
Kobayashi, Kazuyuki, C Allred, & Takeshi Yoshida. (1985). Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.. The Journal of Immunology. 135(5). 2996–3003. 22 indexed citations
16.
Nieburgs, Andra C., et al.. (1985). In vitro growth and maintenance of two morphologically distinct populations of thymic epithelial cells. Cellular Immunology. 90(2). 439–450. 35 indexed citations
17.
Kobayashi, K., C Allred, S Cohen, & Takeshi Yoshida. (1985). Role of interleukin 1 in experimental pulmonary granuloma in mice.. The Journal of Immunology. 134(1). 358–364. 66 indexed citations
18.
Barbour, Alan G., C Allred, C. O. Solberg, & H. R. Hill. (1980). Chemiluminescence by Polymorphonuclear Leukocytes from Patients with Active Bacterial Infection. The Journal of Infectious Diseases. 141(1). 14–26. 103 indexed citations
19.
Shigeoka, Ann O., R T Hall, V G Hemming, C Allred, & Harry R. Hill. (1978). Role of antibody and complement in opsonization of group B streptococci. Infection and Immunity. 21(1). 34–40. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Bradford Kline Breakdown of academic impact, for papers by Matthew L. Hedberg Breakdown of academic impact, for papers by Howard B. Urnovitz Breakdown of academic impact, for papers by Jürgen Siebler Breakdown of academic impact, for papers by Bert Top Breakdown of academic impact, for papers by Sâmia Demachki Breakdown of academic impact, for papers by Paul I. Nadler Breakdown of academic impact, for papers by J Zeromski Breakdown of academic impact, for papers by Hsin‐Pai Li Breakdown of academic impact, for papers by L. Athlin
Rankless by CCL
2026